Conclusion: vitamin A combined with insulin aspart in the treatment of T1DM children can reduce the levels of fasting blood glucose, 2‐h postprandial blood glucose, daily insulin dosage, IL‐17 levels, FGF19 levels and the incidence of complications, and increase the level of serum C‐peptide. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.